Biolab Sanus Farma is one of Brazil's leading pharmaceutical companies, dedicated to developing, producing, and commercializing prescription medicines. With a strong focus on innovation and research, Biolab has a significant presence in areas such as cardiology, gynecology, dermatology, pediatrics, central nervous system (CNS), and orthopedics. The company is committed to improving public health through continuous investment in R&D and partnerships, aiming to provide high-quality therapeutic solutions to patients in Brazil and increasingly, internationally.
The headquarters in Taboão da Serra serves as the central hub for Biolab Sanus Farma's corporate administration, strategic planning, commercial operations, and houses key decision-making functions supporting its national and international activities.
Modern office facilities designed to foster collaboration and innovation, equipped with contemporary infrastructure to support its dynamic operations. While specific architectural awards are not highlighted, the facility reflects the company's growth and commitment to quality.
Biolab fosters a work culture centered on innovation, ethics, collaboration, and people development. There's an emphasis on scientific rigor, continuous learning, and a commitment to making a positive impact on health.
The headquarters is strategically important as it anchors Biolab's operations in Brazil's primary economic region, facilitating access to talent, infrastructure, and key stakeholders. It represents the core of their expanding pharmaceutical business.
Biolab Sanus Farma is actively expanding its global footprint. While its core operations are in Brazil, the company exports to several countries in Latin America. It has established Biolab Pharma Canada to serve the Canadian market and is making strategic moves to enter the U.S. market. This internationalization strategy is supported by investments in new manufacturing facilities designed for export and a focus on innovative products with global potential.
Av. Paulo Ayres, 280 - Pq. Pinheiros
Taboão da Serra
São Paulo
Brazil
Address: Rod. Castello Branco, km 30,5 - Itaqui, Jandira - SP, 06696-000, Brazil
Supports national supply and innovation, forming the backbone of Biolab's pharmaceutical development and manufacturing capabilities.
Address: Specific street address for the new complex may vary, located in Pouso Alegre's industrial district.
Enhances production capacity, supports national and international market supply, and strengthens R&D infrastructure in a strategic region of Brazil.
Address: Information specific to street address not readily public; corporate registration in Ontario.
Serves as a key hub for North American expansion, adapting Biolab's portfolio for the Canadian healthcare system.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Biolab ' leadership includes:
Biolab has been backed by several prominent investors over the years, including:
Biolab Sanus Farma has seen some key appointments to strengthen its executive team, particularly in finance and technology, aligning with its growth and innovation strategies. No major high-profile executive departures have been widely publicized in the recent period.
Discover the tools Biolab uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Biolab Sanus Farma likely uses standard corporate email formats. Common patterns include combining the first name, last name, or initials with the company domain. The most probable domain is @biolabfarma.com.br.
[first_initial][last_name]@biolabfarma.com.br or [first_name].[last_name]@biolabfarma.com.br
Format
c.marques@biolabfarma.com.br (example for Cleiton Marques)
Example
80%
Success rate
Biolab Sanus Farma News • February 27, 2024
Biolab highlights its ongoing investments in Research, Development & Innovation (RD&I), totaling R$450 million for 2024. The company aims to launch 20 new products and conduct 12 clinical studies, focusing on radical innovation....more
Biolab Sanus Farma News • November 13, 2023
Marcelo Billi joins Biolab Sanus Farma as the new Executive Director of Finance and Technology (CFO), bringing extensive experience to drive financial strategy and technological innovation within the company....more
Bnews Saúde • August 1, 2023
Biolab Sanus Farma announced a R$500 million investment in a new state-of-the-art manufacturing plant in Pouso Alegre, Minas Gerais. The facility will significantly expand production capacity for both domestic and international markets....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Biolab , are just a search away.